Zentiva SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zentiva SA with three other pharmaceutical manufacturers in Europe: Cathay International Holdings Ltd of the United Kingdom (2017 sales of £88.59 million [US$124.24 million] ), Bioton SA of Poland (361.65 million Polish New Zlotys [US$106.34 million] of which 59% was Insulin (Bioton SA)), and Solon Eiendom ASA which is based in Norway (883.04 million Norwegian Kroner [US$112.60 million] ).

Sales Analysis. During the year ended December of 2017, sales at Zentiva SA were 458.60 million Romanian Leu (US$120.75 million). This is an increase of 9.2% versus 2016, when the company's sales were 420.00 million Romanian Leu. This was the fifth consecutive year of sales increases at Zentiva SA (and since 2012, sales have increased a total of 76%).